All News

ACR20 Best Abstracts - Day 3

Save

d Jack Cush, MD

Nov 08, 2020

The RheumNow faculty reporters have been scouring and reporting on the best abstracts from the ACR. Here is a sampling of their choice abstract presentations reported during ACR 2020 Day 3 (#ACRbest).

Read Article

Evolution of GCA Treatments - More to Come

Save

d Meral K. El Ramahi, MD, FACP, FACR

Nov 08, 2020

The field of Rheumatology is an ever-nascent field with an incredible expansion in our therapeutic armamentarium over the past half century. An example of such advancement is easily appreciated when reflecting on the innovative treatment approach to Giant Cell Arteri

Read Article

@RheumNow #ACR20 abs1151 screening for inflammatory hyperferritinemia may be feasible but requires additional info: inflammatory huperferritinemia more likely to correlate with ⬆️IL18, AST&thrombocytosis while high CRP+ferritin more often seen in infectious etiology https://t.co/wiFPXepxpz

Olga Petryna DrPetryna ( View Tweet)

Nov 08, 2020

Study of Chinese pts on long-term GCs by Dr CC Mok: DEN >> ALN in ⬆spinal BMD & suppressing bone turnover markers after 1yr tx. No sig. diff in AEs among grps. Limits: Open-label,small ss,short tx dur'n, not powered for fractures @RheumNow #ACR20 abs1442 https://t.co/m8mT0hMPN8

sheila RHEUMarampa ( View Tweet)

Nov 08, 2020

A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011) #ACR20 https://t.co/0Rxv9GjOkw https://t.co/2uOiOZfSfM

Links:

https://bit.ly/2IfFZFL

Dr. John Cush RheumNow ( View Tweet)

Nov 08, 2020

Poll results are in! Most would like to wait for a phase III before prescribing MMF with pegloticase in refractory gout. @RheumNow #ACR20 https://t.co/45MpFliDkE

Links:

https://twitter.com/meralelramahimd/status/1325219148591456257

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Nov 08, 2020

Please join me for a special lecture tomorrow NOON as #ACR breaks through the ceiling to discuss THE SCIENCE OF #empathy - so privileged to do this @RheumNow @CCalabreseDO @HealioRheum @HelenRiessMD https://t.co/TDkLK8GaZJ

Links:

https://twitter.com/LCalabreseDO/status/1314535200152588288

Leonard Calabrese LCalabreseDO ( View Tweet)

Nov 08, 2020

#ACRKnowledgeBowl #acr20 @rheumnow This % of bone loss is assc with a T-score -1.5 on a DXA

k dao KDAO2011 ( View Tweet)

Nov 08, 2020

Learning points from Dr. Janeth Yinh's talk on the utility of #mskus in evaluating painful wrist structures: 👉consider tendon tears in IA 👉consider anatomic variations in pts w/ recalcitrant CTS @RheumNow #ACR20 https://t.co/F2cwxAlfoU

sheila RHEUMarampa ( View Tweet)

Nov 08, 2020

Looking forward to learning lots of #rheumatology "pearls and myths" in this session by Prof. John Stone #ACR20 @RheumNow https://t.co/p6vKd8DZLI

Mrinalini Dey DrMiniDey ( View Tweet)

Nov 08, 2020

Don’t forget to check the eyes. Dr Kolfenbach. Top secret and Pearls #ACR20 @RheumNow It’s also useful for dx #sjogren #sarcoidodis #Ig G4 https://t.co/dxmwuwrPqz

Sole RetamozoSole ( View Tweet)

Nov 08, 2020

Lots of interesting studies in Spondyloarthritis including AxSpA and PsA at #ACR20 @RheumNow https://t.co/tIyqyMdmTf

Links:

https://twitter.com/rheumnow/status/1325475676640645128

Dr. Antoni Chan synovialjoints ( View Tweet)

Nov 08, 2020

@RetamozoSole @RheumNow @Reumaclinic @MAS_Clinic @hospitalclinic #ACR20 Thanks for sharing! but our data show that patients under anti-Cytokine therapy in monotherapy at baseline (specifically anti-IL6 -IL12/23 and -IL17) or under JAKinh were ⬇️LESS likely to be admitted (OR 0.15; 95% CI 0.03-0.66; p=0.012) 📍Limitations: small number of pts https://t.co/zeLzrNLeDQ

Juan Camilo Sarmiento-Monroy jcsam25 ( View Tweet)

Nov 08, 2020